Selected mechanisms of molecular resistance of Candida albicans to azole drugs
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
A phenomenon of increasing resistance of Candida spp. to azoles has been observed for several years now. One of the mechanisms of lack of sensitivity to azoles is associated with CDR1, CDR2, MRD1 genes (their products are active transport pumps conditioning drug efflux from pathogen's cell), and ERG11 gene (encoding lanosterol 14α-demethylase). Test material was 120 strains of Candida albicans (60 resistant and 60 susceptible to azole drugs) obtained from clinical samples. The first stage of experiment assessed the expression of CDR1, CDR2, MDR1 and ERG11 genes by Q-PCR. The impact of ERG11 gene's mutations on the expression of this gene was analysed. The final stage of the experiment assessed the level of genome methylation of Candida albicans strains. An increase in the expression of CDR2, MDR1 and ERG11 was observed in azole-resistant strains of Candida albicans in comparison to strains sensitive to this class of drugs. Furthermore, 19 changes in the sequence of ERG11 were detected in tested strains. Four of the discovered mutations: T495A, A530C, G622A and A945C led to the following amino acid substitutions: D116E, K128T, V159I and E266D, respectively. It has also been found that statistically five mutations: T462C, G1309A, C216T, C1257T and A945C affected the expression of ERG11. The applied method of assessing the level of methylation of Candida albicans genome did not confirm its role in the development of resistance to azoles. The results indicate however, that resistance of Candida albicans strains to azole drugs is multifactorial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Meanwhile, mutations in this pathway, causing alterations in enzymes activity or drug binding sites, are major factors which are related with azole resistance.”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mutations in the ERG11 and ERG3 genes or the UPC2 gene which encodes a transcription factor contribute to azole resistance.”
From The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn (2016) · cites this paper as [42]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 3×
“According to the literature the following molecular mechanisms of drug resistance can be distinguished: modification of the drug target affinity, overproduction of enzymes that are targets to drugs, development of alternative metabolic pathways, active efflux of drugs from the cell, impermeability of the cell membrane…”
BackgroundInfluentialClinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 1×
“In the case of yeast, the products of CDR1 and CDR2 are ABC proteins and products of MDR1 are MFS-type transporters (de Waard et al., 2006; Del Sorbo et al., 2000; Piddock, 2006; Decottignies & Goffeau, 1997).”
BackgroundEpidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610 · cited 2×
“…Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida kru- sei, Candida guilliermondii, Candida lusitaniae, Candida dubliniensis, Candida pelliculosa, Candida kefyr, Candida lipolytica, Candida famata, Candida inconspicua, Candida rugosa and Candida norvegensis (Yapar, 2014).”
BackgroundComplete inventory of the yeast ABC proteins
Decottignies, A., & Goffeau, A. (1997) · Nature Genetics · doi:10.1038/ng0297-137 · Cited by 454 · cited 1×
“In the case of yeast, the products of CDR1 and CDR2 are ABC proteins and products of MDR1 are MFS-type transporters (de Waard et al., 2006; Del Sorbo et al., 2000; Piddock, 2006; Decottignies & Goffeau, 1997).”
BackgroundFungal Transporters Involved in Efflux of Natural Toxic Compounds and Fungicides
Del Sorbo, G., Schoonbeek, H.-J., & De Waard, M. A. (2000) · Fungal Genetics and Biology · doi:10.1006/fgbi.2000.1206 · Cited by 357 · cited 1×
“In the case of yeast, the products of CDR1 and CDR2 are ABC proteins and products of MDR1 are MFS-type transporters (de Waard et al., 2006; Del Sorbo et al., 2000; Piddock, 2006; Decottignies & Goffeau, 1997).”
BackgroundRegulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · cited 2×
“According to the literature the following molecular mechanisms of drug resistance can be distinguished: modification of the drug target affinity, overproduction of enzymes that are targets to drugs, development of alternative metabolic pathways, active efflux of drugs from the cell, impermeability of the cell membrane…”
BackgroundInfluentialImpact of fungal drug transporters on fungicide sensitivity, multidrug resistance and virulence
de Waard, M. A., Andrade, A. C., Hayashi, K., Schoonbeek, H., Stergiopoulos, I., & Zwiers, L. (2006) · Pest Management Science · doi:10.1002/ps.1150 · Cited by 209 · cited 1×
“In the case of yeast, the products of CDR1 and CDR2 are ABC proteins and products of MDR1 are MFS-type transporters (de Waard et al., 2006; Del Sorbo et al., 2000; Piddock, 2006; Decottignies & Goffeau, 1997).”
BackgroundChau, A. S., Mendrick, C. A., Sabatelli, F. J., Loebenberg, D., & McNicholas, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2124-2131.2004 · Cited by 187 · cited 1×
“It is worth emphasizing that the expression was studied using the Relative Quantitation software (RQ) for larger group of strains in comparison to studies by other authors (Chau et al., 2004; Cernicka & Subik, 2006; Goldman et al. 2004; Chen et al. 2010).”
ResultCandida and invasive candidiasis: back to basics
Lim, C. S. Y., Rosli, R., Seow, H. F., & Chong, P. P. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1273-3 · Cited by 170 · cited 3×
“These are mainly opportunistic microorganisms belonging to saprophytic flora inhabiting the gastrointestinal tract, urogenital system, skin, and mucous membranes of the airways (Lim et al., 2012).”
BackgroundPathogenicity and drug resistance in Candida albicans and other yeast species
Mishra, N., Prasad, T., Sharma, N., Payasi, A., Prasad, R., Gupta, D., & Singh, R. (2007) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.54.2007.3.1 · Cited by 168 · cited 2×
“According to the literature the following molecular mechanisms of drug resistance can be distinguished: modification of the drug target affinity, overproduction of enzymes that are targets to drugs, development of alternative metabolic pathways, active efflux of drugs from the cell, impermeability of the cell membrane…”
BackgroundInfluential
Cited by
de Oliveira Santos, G. C., Vasconcelos, C. C., Lopes, A. J. O., de Sousa Cartágenes, M. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 350
Lv, Q.-Z., Yan, L., & Jiang, Y.-Y. (2016) · Virulence · doi:10.1080/21505594.2016.1188236 · Cited by 133
Zieniuk, B., & Fabiszewska, A. U. (2018) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-018-2583-8 · Cited by 106
Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans
Liu, S., Yue, L., Gu, W., Li, X., Zhang, L., & Sun, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150859 · Cited by 87
“In order to identify whether the combinations could also reverse one of the most common resistant mechanism of increased drug efflux, we conducted rhodamine 6G assays to investigate activity of efflux pump protein and RT-PCR to determine gene expression of CDR1, CDR2 andMDR1 [28].”
MethodDu, W., Zhai, P., Wang, T., Bromley, M. J., Zhang, Y., & Lu, L. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01839-20 · Cited by 46
Li, X., Yu, C., Huang, X., & Sun, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168936 · Cited by 44
Wang, B., Huang, L.-H., Zhao, J.-X., Wei, M., Fang, H., Wang, D.-Y., Wang, H.-F., Yin, J.-G., & Xiang, M. (2015) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2015.08.002 · Cited by 37
Bibliometric analysis of literature on antifungal triazole resistance: 1980 – 2015
Sweileh, W. M., Sawalha, A. F., Al‐Jabi, S. W., & Zyoud, S. H. (2017) · GERMS · doi:10.18683/germs.2017.1104 · Cited by 33
“ro • GERMS 7(1) • March 2017 • page 25 suggested.(34,35) For Aspergillus species, mechanisms of resistance involve efflux pump and changes in”
BackgroundDetection of ERG11 point mutations in Iranian fluconazoleresistant Candida albicans isolates
Sardari, A., Zarrinfar, H., & Mohammadi, R. (2019) · Current Medical Mycology · doi:10.18502/cmm.5.1.531 · Cited by 30
“Mutations A369C and T462C have been also identified as possible factors associated with resistance to azole agents [54].”
BackgroundExpression pattern of drug-resistance genes ERG11 and TAC1 in Candida albicans Clinical isolates
Zare-Bidaki, M., Maleki, A., Ghanbarzadeh, N., & Nikoomanesh, F. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07878-0 · Cited by 15
“According to the literature, there is a keen interest in research on molecular mechanisms of antifungal resistance [14, 15].”
BackgroundMethodMalik, A. K., Singh, C. S., Tiwari, P., Verma, D., Mehata, A. K., Vikas, V., Setia, A., Mukherjee, A., & Muthu, M. S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130154 · Cited by 12
Benedetti, V. P., Savi, D. C., Aluízio, R., Adamóski, D., Kava, V. M., Galli-Terasawa, L. V., & Glienke, C. (2019) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0473-2018 · Cited by 14
Yenişehirli, G., Alıcı, A., & Yenişehirli, A. (2023) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2023.100389 · Cited by 12
Cotreatment with Aspirin and Azole Drugs Increases Sensitivity of Candida albicans in vitro
Feng, W., Yang, J., Ma, Y., Xi, Z., Ji, Y., Ren, Q., Ning, H., & Wang, S. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s314538 · Cited by 11
Antifungal drug resistance Candida spp. mechanisms in reccurent genital candidiasis
Bezhenar, M. B., & Plakhova, X. I. (2020) · Molecular Genetics Microbiology and Virology (Russian) · doi:10.17116/molgen20203801115 · Cited by 9
Moron, L. (2018) · Current Research in Environmental & Applied Mycology · doi:10.5943/cream/8/3/1 · Cited by 7
Sawadogo, P., Zida, A., Sangaré, I., Guiguemdé, T., Sanfo, A., Idani, M., Nacanabo, H., Bamba, S., Traoré, R., & Guiguemdé, T. R. (2019) · Journal of Infectiology · doi:10.29245/2689-9981/2019/4.1143 · Cited by 6
Коваленко, Н. І., Замазій, Т. М., & Novikova, I. V. (2020) · ACTUAL INFECTOLOGY · doi:10.22141/2312-413x.8.5-6.2020.217956 · Cited by 3
Abedzadeh, A., Dakhili, M., Saghazadeh, M., Aghaei, S., & Nazari, R. (2022) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-124602 · Cited by 3
Antifungal Activity of Origanum syriacum L. Essential Oils against Candida spp.
Duran, N., & Kaya, D. A. (2018) · ICAMS · doi:10.24264/icams-2018.i.11 · Cited by 3
Bezhenar, M. B., & Plakhova, X. I. (2020) · Molecular Genetics Microbiology and Virology · doi:10.3103/s0891416820010024 · Cited by 2
Candida albicans, from endodontic point of view
Perez, V. V., Treviño-Tijerina, M. C., Leal-Camarillo, J. N., Rodriguez, L. E. Q., Rangel, S. S., Sánchez-Najéra, R. I., & Solís-Soto, J. M. (2021) · International Journal of Applied Dental Sciences · doi:10.22271/oral.2021.v7.i3b.1282 · Cited by 2
“to azoles has been observed for several years, one of the mechanisms of lack of sensitivity to azoles is associated with CDR1, CDR2 and MRD1 genes ([37]).”
BackgroundDokht, E. A., Anvari, M., & Ranji, N. (2015) · Cited by 5
CanDRes: Exploring the Mutation Landscape of Candida and its Role in Antifungal Resistance
Kumar, C., Arshi, A., Yadav, A., Chavan, P., & Idicula‐Thomas, S. (2025) · Infection · doi:10.1007/s15010-025-02686-7 · Cited by 1
“This resistance mechanism has been observed in clinical strains of C. albicans [3], and the presence of ERG3 mutations in various Candida spp. indicates a similar emerging resistance mechanism (Fig.”
Sawadogp, M. P., Zida, A., Soulama, I., Sermé, S. S., Guiguemdé, T. K., Sangaré, I., Kafando, C., Bamba, S., Ouedraogo-Traoré, R., & Guiguemdé, R. T. (2021) · Preprints.org · doi:10.20944/preprints202102.0045.v1
Umer, M. M. (2023) · Journal of University Medical & Dental College · doi:10.37723/jumdc.v14i4.856
Bilbao Bilbao, N. (2018) · Communities in ADDI (Universidad del Pais Vasco)
Metadata
- Authors
- Gołąbek, K., Strzelczyk, J. K., Owczarek, A., Cuber, P., Ślemp-Migiel, A., & Wiczkowski, A.
- Affiliations
- Medical University of Silesia (PL)
- Laboratory of Microbiology in Hospital in Nowy Targ, Nowy Targ, Poland
- ORCID
- Venue
- Acta Biochimica Polonica
- Publisher
- Frontiers Media SA
- Published
- 2015
- Volume
- 62
- Issue
- 2
- Pages
- 247-251
- ISSN
- 0001-527X (ISSN-L)
- 1734-154X
- OpenAlex
- W2165858950
- Cited by
- 26
- References
- 22
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 3 · 2015: 2
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Acta Biochimica Polonica (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Uniwersytet Łódzki
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida albicans, azole resistance, antifungal resistance, CDR1, CDR2, MDR1, ERG11, lanosterol 14α-demethylase, drug efflux pumps, gene expression, ERG11 mutations, multidrug resistance
- MeSH terms
- Antifungal Agents, Azoles, Candida albicans, Cytochrome P-450 Enzyme System, Fungal Proteins, Humans, Mutation, Gene Expression Regulation, Fungal, DNA Methylation, ATP Binding Cassette Transporter, Subfamily B, Member 1, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.